相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy
Avinash Eranki et al.
CLINICAL CANCER RESEARCH (2020)
Combination Therapy with Doxorubicin-Loaded Reduced Albumin Nanoparticles and Focused Ultrasound in Mouse Breast Cancer Xenografts
Daehyun Kim et al.
PHARMACEUTICALS (2020)
Immune-Related Adverse Drug Reactions and Immunologically Mediated Drug Hypersensitivity
Eric Macy
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2020)
Immunomodulation of intracranial melanoma in response to blood-tumor barrier opening with focused ultrasound
Colleen T. Curley et al.
THERANOSTICS (2020)
The Promise of Neoadjuvant Immunotherapy and Surgery for Cancer Treatment
Jake S. O'Donnell et al.
CLINICAL CANCER RESEARCH (2019)
Side effects of immunotherapy: a constant challenge for oncologists
Florian Scotte et al.
CURRENT OPINION IN ONCOLOGY (2019)
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam et al.
NATURE REVIEWS MATERIALS (2019)
Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities
Guilian Shi et al.
CANCER BIOLOGY & MEDICINE (2019)
Combination therapy strategies for improving PD-1 blockade efficacy: a new era in cancer immunotherapy
P. S. Chowdhury et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
Shetal A. Patel et al.
IMMUNITY (2018)
Mechanical fractionation of tissues using microsecond-long HIFU pulses on a clinical MR-HIFU system
Avinash Eranki et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2018)
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
Wantong Song et al.
NATURE COMMUNICATIONS (2018)
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
[Anonymous]
NATURE REVIEWS DRUG DISCOVERY (2018)
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
Christopher J. LaRocca et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
PD-1/PD-L1 and immunotherapy for pancreatic cancer
Mengyu Feng et al.
CANCER LETTERS (2017)
Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer Models
Chunxiao Xu et al.
CLINICAL CANCER RESEARCH (2017)
Ultrasound-guided drug delivery in cancer
Sayan Mullick Chowdhury et al.
ULTRASONOGRAPHY (2017)
Delivering safer immunotherapies for cancer
Lauren Milling et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Current understanding of interactions between nanoparticles and the immune system
Marina A. Dobrovolskaia et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic Cancer
Tong Li et al.
CANCER RESEARCH (2015)
Releasing the Brakes on Cancer Immunotherapy
Antoni Ribas
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Programmed Death-1 Immune-Suppressive Pathway: Barrier to Antitumor Immunity
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2014)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
High intensity focused ultrasound ablation and antitumor immune response
Feng Wu
JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA (2013)
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
Christel Devaud et al.
ONCOIMMUNOLOGY (2013)
Adverse events to monoclonal antibodies used for cancer therapy Focus on hypersensitivity responses
Brian A. Baldo
ONCOIMMUNOLOGY (2013)
Ultrasound-Induced Blood-Brain Barrier Opening
Elisa E. Konofagou et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
VASCULAR EFFECTS OF MICROBUBBLE-ENHANCED, PULSED, FOCUSED ULTRASOUND ON LIVER BLOOD PERFUSION
Yuejuan Gao et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2012)
Quantitative and qualitative investigation into the impact of focused ultrasound with microbubbles on the triggered release of nanoparticles from vasculature in mouse tumors
Chung-Yin Lin et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Boosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturation
Fang Liu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies
Frank R. Brennan et al.
MABS (2010)
The immunogenicity of humanized and fully human antibodies Residual immunogenicity resides in the CDR regions
Fiona A. Harding et al.
MABS (2010)
Dose Escalation Methods in Phase I Cancer Clinical Trials
Christophe Le Tourneau et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Overview of monoclonal antibodies in cancer therapy: present and promise
M Stern et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation
F Wu et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2004)
分享论文
